Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Drugmakers Oppose Teva Bid to Delay Copaxone Rivals
Bloomberg
Monday, April 14, 2014 - 7:08pm
tags:
Teva, Copaxone, MS, multiple sclerosis, Momenta, generics, Sandoz, Mylan
Novartis to Shire Said to Weigh Bids for ThromboGenics
Bloomberg
Monday, April 14, 2014 - 6:49pm
tags:
Shire, ThromboGenics, Novartis, Roche, Valeant Pharmaceuticals, Regeneron, Allerg
New attention disorder could equal a big new ADHD drug market
Fierce Pharma
Monday, April 14, 2014 - 6:27pm
tags:
Strattera, Sluggish Cognitive Tempo, Shire, Eli Lilly, attention deficit disorder, ADD
Alnylam slips after Novartis reportedly cuts back RNAi development
The Fly on the Wall
Monday, April 14, 2014 - 6:22pm
tags:
Novartis, Alnylan, RNAi
[video]Amgen's Conundrum
Motley Fool
Monday, April 14, 2014 - 6:18pm
tags:
Amgen, Talimogene Laherparepvec
Eli Lilly vs. Canada: The Patent War Moves to Washington
WSJ Online
Monday, April 14, 2014 - 6:15pm
tags:
Canada, patents, Eli Lilly
Akorn gets U.S. approval to buy Hi-Tech Pharmacal, with conditions
Yahoo/Reuters
Monday, April 14, 2014 - 6:14pm
tags:
Hi-Tech Pharmacal, Akorn, M&A
The Uncertain Future Of A Once Highly Promising Device For Lowering Blood Pressure
Forbes
Monday, April 14, 2014 - 12:44pm
tags:
devices, Boston Scientific, RDN, Symplicity, hypertension
J&J says halting development of Botox rival
Yahoo/Reuters
Monday, April 14, 2014 - 12:41pm
tags:
JNJ, Botox, Allergan, PurTox
Novartis Wins Court Order Blocking U.K. Animal-Rights Protests
Bloomberg
Monday, April 14, 2014 - 12:40pm
tags:
Novartis, animal research
What Arena's Belviq Television Ad Campaign Means For The Stock
Seeking Alpha
Monday, April 14, 2014 - 12:37pm
tags:
Arena Pharmaceuticals, drug ads, Belviq
Impax Breathes New Life Into Stalled Parkinson's Drug
Motley Fool
Monday, April 14, 2014 - 11:52am
tags:
Impax Labs, Parkinson's Disease, GSK, Rytary
Retrophin disappointed FDA won't grant expedited access to RE-024 for children
Yahoo/Fly on the Wall
Monday, April 14, 2014 - 11:47am
tags:
FDA, Retrophin, RE-024, PKAN
Mylan to Settle with Endo on Frova
Yahoo/Zacks.com
Monday, April 14, 2014 - 11:40am
tags:
Mylan, Endo Health Solutions, Frova, migraines
NeoStem Announces Definitive Agreement to Acquire California Stem Cell, Inc.
Yahoo
Monday, April 14, 2014 - 8:46am
tags:
NeoStem, California Stem Cell, M&A, melanoma
Vivus needs more than boardroom shuffling to keep up with Arena's Belviq
Fierce Pharma
Monday, April 14, 2014 - 8:42am
tags:
Belviq, Vivus, obesity, Arena Pharmaceuticals, Qsymia
GSK faces criminal bribery investigation in Poland
Reuters
Monday, April 14, 2014 - 8:40am
tags:
GSK, bribery, Pioland
Deadly Bowel Infection Draws Drugmakers Seeking Cures
Bloomberg
Monday, April 14, 2014 - 8:37am
tags:
Merck, Sanofi, Actelion, Shire, Clostridium Difficile
Price of New Hepatitis C Drugs Not So Daunting After All
Bloomberg
Monday, April 14, 2014 - 8:35am
tags:
drug pricing, hepatitis C, Sovaldi, Gilead Sciences
Oncolytics Biotech reports evaluation of clinical study with REOLYSIN
The Fly on the Wall
Monday, April 14, 2014 - 8:26am
tags:
Oncolytics, Reolysin, hepatitis B, hepatitis C, liver cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.